Wellness Supplement

Ionix Supreme

28 adverse event reports submitted to the FDA · 2009–2018 · Data current as of June 3, 2026

These are reports submitted to the FDA. A report does not mean the product caused the effect. Counts reflect reporting activity, not how common an effect is.

Most Reported Reactions

Top 10 reactions from 28 reports. One report may include multiple reactions — reaction totals may exceed the report count.

Nausea
7
Vomiting
5
Urticaria
5
Hypersensitivity
4
Dizziness
2
Headache
2
Oropharyngeal Swelling
2
Diarrhoea
2
Abdominal distension
2
Abdominal pain upper
2

Reported Outcomes

Outcome categories as recorded in FDA reports. One report may include multiple outcomes.

OutcomeReports
Hospitalization 19
Life Threatening 10
Visited Emergency Room 7
Visited a Health Care Provider 4
Other Serious or Important Medical Event 2
Other Serious Outcome 1

Who Reported

Reporter demographics where available. Many reports do not include age or gender data.

Age

Under 18
0
18–34
6
35–49
7
50–64
7
65–79
2
80+
1
Unknown
5

23 reports had age data; 5 unknown.

Gender

Female
25
Male
2
Unknown/Not Reported
1

Reports by Year

Annual report counts from 2009–2018. Spike years may reflect recalls, media coverage, or litigation rather than changes in the product.

'09
'10
'11
'12
'13
'14
'15
'16
'17
'18

Hover bars for exact counts.

Data Source

This page presents data from the FDA's CFSAN Adverse Event Reporting System (CAERS) via the openFDA API. Reports are voluntary and unverified. The FDA has not concluded that this product caused any reported event.

View openFDA CAERS data ↗  ·  About our methodology  ·  How to read this data